Host: |
Goat |
Applications: |
Pep-ELISA/WB/IF/FC |
Reactivity: |
Human/Rat/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-ACHE (C-Term) is suitable for use in ELISA, Western Blot, Immunofluorescence and Flow Cytometry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
WB-0.3-1µg/mlIF-Strong expression of the protein seen in the cytoplasm and nucleus of U2OS cells. 10µg/mlELISA-antibody detection limit dilution 1:64000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
ACHE |
Gene ID: |
43 |
Uniprot ID: |
ACES_HUMAN |
Immunogen Region: |
C-Term |
Accession Number: |
NP_000656.1; NP_001269378.1 |
Specificity: |
This antibody is expected to recognise isoform NP_000656.1 only (the ubiquitously expressed, hydrophillic form). |
Immunogen Sequence: |
QFDHYSKQDRCSDL |
Function | Hydrolyzes rapidly the acetylcholine neurotransmitter released into the synaptic cleft allowing to terminate the signal transduction at the neuromuscular junction. Role in neuronal apoptosis. |
Protein Name | AcetylcholinesteraseAche |
Database Links | Reactome: R-HSA-112311Reactome: R-HSA-1483191Reactome: R-HSA-422085 |
Cellular Localisation | SynapseSecretedCell MembranePeripheral Membrane ProteinIsoform T: NucleusOnly Observed In Apoptotic NucleiIsoform H: Cell MembraneLipid-AnchorGpi-AnchorExtracellular Side |
Alternative Antibody Names | Anti-Acetylcholinesterase antibodyAnti-Ache antibodyAnti-ACHE antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance